Anti-PD1 antibody
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Anti-PD1 antibody, covering 2021-08-23 to 2025-03-14. Get the full timeline:
Most recent: Clinical Trial Update: CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer [Phase 2]